Levy L S, Fish R E, Baskin G B
Department of Microbiology and Immunology, Tulane Medical Center, New Orleans, Louisiana 70112.
J Virol. 1988 Dec;62(12):4770-3. doi: 10.1128/JVI.62.12.4770-4773.1988.
The oncogenic capacity of a myc-containing strain of feline leukemia virus (FeLV), termed LC-FeLV, has been examined after inoculation of the virus into neonatal kittens. Like other myc-containing strains of FeLV, LC-FeLV may induce with relatively short latency, but does not necessarily induce, thymic lymphosarcoma in viremic animals. Naturally occurring and experimentally induced tumors are T-cell lymphomas which contain clonally integrated LC-FeLV proviral DNA and which cannot readily be cultivated in vitro in the presence or absence of exogenously supplied interleukin-2. Acquisition of myc by FeLV decreases the period of latency before the appearance of tumors but does not expand the spectrum of tumors induced by FeLV alone.
一种含有myc的猫白血病病毒(FeLV)毒株,称为LC-FeLV,在将其接种到新生小猫体内后,对其致癌能力进行了检测。与其他含有myc的FeLV毒株一样,LC-FeLV可能在相对较短的潜伏期内诱发,但不一定会在病毒血症动物中诱发胸腺淋巴肉瘤。自然发生和实验诱导的肿瘤是T细胞淋巴瘤,其中含有克隆整合的LC-FeLV前病毒DNA,无论有无外源性供应的白细胞介素-2,都不能在体外轻易培养。FeLV获得myc会缩短肿瘤出现前的潜伏期,但不会扩大仅由FeLV诱导的肿瘤谱。